Investment Q&A

Q: Is ABCL a buy, hold or sell at this point ? Thanks for this great service.

Q: Could you please comment on ABCL and TCX's current Q and more importantly, their forward guidance. Both stocks are part of my speculative basket and if you were me, would you continue to hold these or move on.? If you would move on what would you replace them with.

Many thanks

Scott

Q: Hello Peter and team
What is your view on Abcellra's results? I was expecting tick upwards. Please comment and does this look like a long term hold as i am thinking of selling Ballard to put more into ABCL. Thanks very much

Q: I've been following these stocks for some time and while all risk picks, they do have some appeal to me. They've also all been beaten down the last while - do you have any thoughts on which of these you would find the most appealing currently, or how you would rank them?

Thank you for your advice and all the information you provide.
Evan

Q: Hello Peter and team,
Can you expand on your answer please on Topicus and Nuvei? You had indicated these are good growth names but add when there is a sustained recovery in tech.. how does one gauge it? Do we use technical analysis and also it seems that yield curve may flatten should that not bode well for tech? With rising rates, banks are supposed to do well but i see a decline.. Is the view now that only short term rates will go up and long term may not go up much; lastly, do you think Abcellara is a good buy now?

Q: I believe earnings were out last week. Could you give me your opinion on the earnings and the company.
Thanks John

Q: Should have asked this question months ago,oh well hindsight is a great thing,these stocks are all 2% positions down from 22% to 81%,mostly all Motley Fool misfires
I want to do some housekeeping for a continued 1-2 year hold or sell and move on could you tell me which ones to unload ....Thanks

Q: Good day. A little over 1 year ago I allocated about 5% of my portfolio to the high growth/risk stocks. Needles to stay it hasn't worked out as expected. At this stage I am hoping that you can give me insight what the future holds for these companies as an investment. Which should be sold and subsequently move the funds moved into the keepers.
Deduct as many credits as you feel appropriate.
Much appreciated

Q: I'm down significantly on ABCL. Your thoughts on the company? Cut my loses or hang on?

Q: Hello Peter and Ryan,
What is happening with Tecsys? Is it just the current market conditions bringing town tech related stocks? I would have thought with the current covid situation, Abcellera Biologics would be doing much better but the stock continues to slide? With respect to curaleaf, why is the stock experiencing so much volatility when it is one of the leaders and the revenues are decent? Thanks very much

Q: I have done alot of tax loss selling, starting in Oct. The stocks include XBC, CHEWY, LMND, PINS, RDFN, TDOC, EGLX, REAL, MRS, ABCL, and ZNGA. Which ones would you repurchase? Would you do it now, or wait until the new year? I purchased LSPD, NVEI , and APPS with some of the proceeds, and that has not worked out well! Would you average down on these names when they stabilize?

Q: Hello team,

I have to crystalize some losses to offset gains. I have a substantial position in ABCL (-56%) and BHC (-78%) and can sell either completely and be done with offsetting the gains. Do you suggest I do that or should I get rid of SDGR (-23%), BMBL (-38%) and PENN (-23%) as well ,if ABCL is worth holding onto, at least partially?

I know other than BHC, they all do have a good bounce potential after the tax-loss season is over. However, I also know that something like BMBL or even ABCL may be broken stories and may take a very long time to recover.

I appreciate it if you can share in which order you would sell and why (if you could kindly include the main reason for each).

Best!

Q: Is a Canadian company like Abcellera, that trades only on a U.S. exchange, considered foreign property?

Q: Hi 5i - From the following 9 US stocks - which 3 would you have the highest conviction for (with a short why for each): AFRM, ABCL, GOOG, AAPL, COST, CRWD, FLGT, NVDA, NKE

Q: Hello Peter,
You are positive on AbCellera Biologics Inc.but the stock continues to tumble.. Other than Merck's announcement, i dont see any other news to create the decline.. .I am thinking of averaging down. Also, Greenlane is taking hits as well .. Do you think it is worth averaging down on this one as well?

Q: ABCL is down sharply today. Is there any news? Is it a 'buy' at this price?
With appreciation.
Ed

Q: Good morning 👀 👀 👀 👀 👀

How significant do you feel the after hour news for ABCL is? Would you buy or add on it? Any thoughts on it's relationship with Moderna and the ongoing potential of the company in general is much appreciated?

thanks, M

Q: I have new US $ 20k to purchase US listed stocks. Please rank buying order of the above stocks for long term growth and reasons if possible. Thank you kindly. Bill

Q: Would you rather hold 1 position in NVDA or the equivalent of 1 position in a "basket" of FLGT, MELI, AFRM, and ABCL?

Q: Thoughts on the quarter?

Thanks,

Dave